-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
5 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$243,481 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$9.42 M
Ligand Pharmaceuticals Incorporated Insider Transactions
Ligand Pharmaceuticals Incorporated Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Korenberg Matthew E
President & COO |
Sell | 2,481 @ $100.05 | $248,228 | 58,068 | 09/23/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 7,090 @ $101.61 | $720,379 | 50,978 | 09/23/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 201 @ $102.05 | $20,513 | 50,777 | 09/23/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 200 @ $103.98 | $20,796 | 25,685 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 275 @ $103.86 | $28,562 | 25,410 | 09/20/2024 | 09/24/2024 | |
Espinoza Octavio
CFO |
Sell | 800 @ $103.95 | $83,160 | 24,610 | 09/20/2024 | 09/24/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,275 @ $104.10 | $653,238 | 50,777 | 09/20/2024 | 09/24/2024 | |
Reardon Andrew
CLO & Secretary |
Sell | 1,500 @ $106.39 | $159,591 | 22,534 | 08/28/2024 | 08/30/2024 | |
Korenberg Matthew E
President & COO |
Sell | 6,177 @ $105.02 | $648,684 | 54,722 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 5,212 @ $106.32 | $554,147 | 49,510 | 08/26/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 2,037 @ $104.09 | $212,040 | 65,174 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 4,275 @ $105.13 | $449,439 | 60,899 | 08/23/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 1,157 @ $105.54 | $122,110 | 67,211 | 08/22/2024 | 08/26/2024 | |
Korenberg Matthew E
President & COO |
Sell | 18,245 @ $98.50 | $1.80 M | 68,368 | 08/09/2024 | 08/13/2024 | |
Davis Todd C
CEO |
Buy | 2,500 @ $97.39 | $243,481 | 123,010 | 08/08/2024 | 08/09/2024 | |
Espinoza Octavio
CFO |
Sell | 134 @ $86.65 | $11,611 | 23,379 | 05/17/2024 | 05/17/2024 | |
Espinoza Octavio
CFO |
Sell | 5,022 @ $86.67 | $435,233 | 23,513 | 05/17/2024 | 05/17/2024 | |
Espinoza Octavio
CFO |
Sell | 2,264 @ $86.00 | $194,712 | 21,618 | 05/16/2024 | 05/17/2024 | |
Espinoza Octavio
CFO |
Sell | 5,873 @ $86.01 | $505,148 | 23,882 | 05/15/2024 | 05/17/2024 | |
Korenberg Matthew E
President & Chief Operating |
Sell | 13,638 @ $85.08 | $1.16 M | 86,783 | 05/14/2024 | 05/15/2024 |
Ligand Pharmaceuticals Incorporated Frequently Asked Questions
-
Who is on Ligand Pharmaceuticals Incorporated's Insider Roster?
The list of insiders at Ligand Pharmaceuticals Incorporated includes Espinoza Octavio, Sabba Stephen L, Gray Nancy Ryan, Reardon Andrew, Korenberg Matthew E, Davis Todd C.
-
How much insider selling is happening at Ligand Pharmaceuticals Incorporated?
Insiders have sold a total of 99,783 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 9.42 M sold.
-
Which Ligand Pharmaceuticals Incorporated insiders have been selling company stock?
The following insiders have sold Ligand Pharmaceuticals Incorporated shares in the last 12 months: Espinoza Octavio ($1.29 M), Sabba Stephen L ($140,650), Gray Nancy Ryan ($77,713), Reardon Andrew ($990,040), Korenberg Matthew E ($6.92 M),
-
How much insider buying is happening at Ligand Pharmaceuticals Incorporated?
Insiders have purchased a total of 2,500 Ligand Pharmaceuticals Incorporated shares in the last 12 months for a total of 243,481 sold.
-
Which Ligand Pharmaceuticals Incorporated insiders have been buying company stock?
The following insiders have purchased Ligand Pharmaceuticals Incorporated shares in the last 12 months: Davis Todd C ($243,481),